(Q37939790)

25 August 2017

1 reference

title

Is the treatment of hepatocellular carcinoma on the waiting list necessary? (English)

1 reference

25 August 2017

main subject

hepatocellular carcinoma

1 reference

6

Daniel Cherqui

1 reference

25 August 2017

Pietro Majno

1

1 reference

25 August 2017

Riccardo Lencioni

2

1 reference

25 August 2017

Françoise Mornex

3

1 reference

25 August 2017

Nicolas Girard

4

1 reference

25 August 2017

Ronnie T Poon

5

1 reference

25 August 2017

publication date

1 October 2011

1 reference

25 August 2017

published in

Liver Transplantation

1 reference

25 August 2017

volume

17 Suppl 2

1 reference

25 August 2017

page(s)

S98-108

1 reference

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

25 August 2017

cites work

1 reference

A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy

21 January 2018

1 reference

Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list

21 January 2018

1 reference

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study

21 January 2018

1 reference

Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma

21 January 2018

1 reference

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.

21 January 2018

1 reference

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data

21 January 2018

1 reference

Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy.

21 January 2018

1 reference

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation

21 January 2018

1 reference

A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation.

21 January 2018

1 reference

Waiting list removal rates among patients with chronic and malignant liver diseases.

21 January 2018

1 reference

Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis.

21 January 2018

1 reference

Living donor liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation

21 January 2018

1 reference

Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan

21 January 2018

1 reference

Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma: Ablate and wait versus rapid transplantation

21 January 2018

1 reference

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Loco-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation.

21 January 2018

1 reference

Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.

21 January 2018

1 reference

Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation

21 January 2018

1 reference

High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

21 January 2018

1 reference

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial

21 January 2018

1 reference

Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety

21 January 2018

1 reference

Multifaceted perspective of the waiting list for liver transplantation: the value of pharmacokinetic models

21 January 2018

1 reference

Cost analysis of tumor downsizing for hepatocellular carcinoma liver transplant candidates.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/LT.22391

1 reference

25 August 2017

1 reference